MarketsSingle-source
2.1
Double Bond Pharma reports Q2 2026 operating loss of 0.6 million SEK
Dagens IndustriLO·SE·about 11 hours ago
Swedish research firm Irlab narrowed its operating loss to 16.7 million SEK in Q2 2026, compared to a 25.7 million SEK loss in the same period last year. The report reflects ongoing cash burn typical of early-stage research companies, though the year-over-year improvement suggests a reduction in operational expenditure.